<DOC>
	<DOCNO>NCT01773096</DOCNO>
	<brief_summary>The purpose study determine whether routine use methylnaltrexone post-operative pediatric spinal fusion patient decrease incidence constipation .</brief_summary>
	<brief_title>Methylnaltrexone Use Opioid-induced Postoperative Constipation</brief_title>
	<detailed_description>Methylnaltrexone give pediatric patient post-operative spinal fusion surgery post-operative day number 3 postoperative day number 4 , laxation achieve . Various outcome measure , safety efficacy drug observe record .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Bismuth subsalicylate</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<mesh_term>Bisacodyl</mesh_term>
	<mesh_term>Magnesium Hydroxide</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>spinal fusion surgery current opioid use 12 year age old inadequate bowel movement postoperative day 3 know expected mechanical bowel obstruction know suspected lesion GI tract unexpected transfer ICU unexpected return operate room patient parent refusal methylnaltrexone incomplete data concern time laxation</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>opioid-induced</keyword>
</DOC>